Aldose reductase inhibitory compounds from Xanthium strumarium
Ha Na Yoon1, Min Young Lee, Jin-Kyu Kim
1Department of Food Science and Nutrition, Hallym University, Chuncheon, 200-702, Korea.
Researchers explored Xanthium strumarium for natural diabetic complication treatments. Methyl-3,5-di-O-caffeoylquinate demonstrated potent inhibition of aldose reductase and reduced galactitol formation, suggesting its therapeutic potential.
Area of Science:
- Pharmacology
- Natural Products Chemistry
- Biochemistry
Background:
- Diabetic complications are a major health concern.
- Aldose reductase (AR) plays a key role in diabetic complications by promoting galactitol formation.
- Natural products are a promising source for novel therapeutic agents.
Purpose of the Study:
- To investigate the potential of Xanthium strumarium fruit components as inhibitors of aldose reductase (AR).
- To identify specific compounds from X. strumarium that can prevent diabetic complications by inhibiting AR and galactitol formation.
Main Methods:
- Isolation and structural elucidation of 10 compounds from X. strumarium.
- In vitro assays to evaluate the inhibitory effects of isolated compounds on rat lens AR (rAR) and recombinant human AR (rhAR).
- Kinetic analysis (Lineweaver-Burk plots) to determine the inhibition mechanism.
- Assessment of galactitol formation inhibition in rat lenses and erythrocytes.
Main Results:
- Ten compounds, including 7 caffeoylquinic acids and 3 phenolic compounds, were isolated and identified.
- Methyl-3,5-di-O-caffeoylquinate exhibited potent inhibition of rAR (IC₅₀ = 0.30 μM) and rhAR (IC₅₀ = 0.67 μM).
- Methyl-3,5-di-O-caffeoylquinate competitively inhibited rhAR and effectively reduced glucose-induced galactitol formation in vitro.
Conclusions:
- Methyl-3,5-di-O-caffeoylquinate is a potent aldose reductase inhibitor derived from X. strumarium.
- This compound demonstrates potential for preventing diabetic complications by inhibiting galactitol accumulation.
- X. strumarium is a valuable source of natural compounds with therapeutic applications for diabetes management.
Related Concept Videos
Phase I Reactions: Reductive Reactions
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are typically...
Redox Titration: Other Oxidizing and Reducing Agents
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Oxidation of Phenols to Quinones
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox property is crucial in...
Alcohols from Carbonyl Compounds: Reduction
Catalytic hydrogenation is similar to the reduction of an alkene or alkyne by adding H2 across the pi bond in the presence of transition metal catalysts like Raney Ni, Pd–C, Pt, or Ru. Aldehydes and ketones can be reduced by this method, often under mild to moderate heat (25–100°C) and...
